Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Peripheral Arterial Disease D058729 7 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Morozov VI et al. Sphingosine-1-phosphate: distribution, metabolism and role in the regulation of cellular functions. 2013 Jan-Feb Ukr Biokhim Zh (1999) pmid:23534286
Matheu MP et al. Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy. 2013 PLoS ONE pmid:23533579
Arce FT et al. Heterogeneous elastic response of human lung microvascular endothelial cells to barrier modulating stimuli. 2013 Nanomedicine pmid:23523769
Wallington-Beddoe CT et al. Oncogenic properties of sphingosine kinases in haematological malignancies. 2013 Br. J. Haematol. pmid:23521541
Yonesu K and Nara F [Anti-angiogenic effect of bioactive lipid antagonists]. 2012 Nippon Rinsho pmid:23513926
Barth BM et al. Gaucher's disease and cancer: a sphingolipid perspective. 2013 Crit Rev Oncog pmid:23510065
Bendall LJ and Basnett J Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells. 2013 Curr. Opin. Hematol. pmid:23507960
Loetscher E et al. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors. 2013 Biochem. Biophys. Res. Commun. pmid:23499842
Tran-Dinh A et al. HDL and endothelial protection. 2013 Br. J. Pharmacol. pmid:23488589
Yang L et al. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. 2013 J. Hepatol. pmid:23466305
Erkhembaatar LO et al. Increased expression of sphingosine kinase in the amnion during labor. 2013 Placenta pmid:23462226
Natarajan V et al. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23449739
Reichardt P et al. A role for LFA-1 in delaying T-lymphocyte egress from lymph nodes. 2013 EMBO J. pmid:23443048
Gaveglio VL et al. Phosphatidic acid metabolism in rat liver cell nuclei. 2013 FEBS Lett. pmid:23439070
Kusch A et al. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. 2013 Acta Physiol (Oxf) pmid:23432924
Kawahara S et al. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells. 2013 Anticancer Drugs pmid:23426175
Camacho L et al. Acid ceramidase as a therapeutic target in metastatic prostate cancer. 2013 J. Lipid Res. pmid:23423838
Mudd JC et al. Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. 2013 Blood pmid:23422746
Ono Y et al. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. 2013 Lipids Health Dis pmid:23418753
Dusaban SS et al. Phospholipase C epsilon links G protein-coupled receptor activation to inflammatory astrocytic responses. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23401561
Southern C et al. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. 2013 J Biomol Screen pmid:23396314
Camprubí-Robles M et al. Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor. 2013 J. Neurosci. pmid:23392686
Yangyuoru PM et al. Fluorescent lipids as probes for sphingosine kinase activity by capillary electrophoresis. 2013 Methods Mol. Biol. pmid:23386355
Lee YJ et al. Sphingosine-1-phosphate protects against bisphosphonate‑induced HUVEC cell death via regulation of c-Jun‑N‑terminal kinase signaling. 2013 Int. J. Mol. Med. pmid:23381659
Chang CH et al. Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. 2013 Acta Pharmacol. Sin. pmid:23377549
Salata D et al. [Sphingosine-1-phosphate--molecular maestro]. 2012 Postepy Biochem. pmid:23373414
Finley A et al. Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. 2013 PLoS ONE pmid:23372844
Babahosseini H et al. Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. 2012 Conf Proc IEEE Eng Med Biol Soc pmid:23366417
Tong X et al. High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate. 2013 Cardiovasc Diabetol pmid:23360427
Dillahunt SE et al. Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined. 2013 J. Immunol. pmid:23359503
Sharma N et al. Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. 2013 J. Leukoc. Biol. pmid:23345392
Cortez-Retamozo V et al. Angiotensin II drives the production of tumor-promoting macrophages. 2013 Immunity pmid:23333075
Yasuo M et al. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. 2013 PLoS ONE pmid:23326540
Lotinun S et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. 2013 J. Clin. Invest. pmid:23321671
Tibolla G et al. Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis. 2013 PLoS ONE pmid:23320105
Salvemini D et al. Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain. 2013 Trends Pharmacol. Sci. pmid:23318139
Huang LS et al. Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. 2013 FASEB J. pmid:23315259
Watson DG et al. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells. 2013 Cell. Signal. pmid:23314175
Kim YD et al. Effects of sphingosine-1-phosphate on pacemaker activity of interstitial cells of Cajal from mouse small intestine. 2013 Mol. Cells pmid:23307289
Osawa Y et al. Liver acid sphingomyelinase inhibits growth of metastatic colon cancer. 2013 J. Clin. Invest. pmid:23298833
Heffernan-Stroud LA and Obeid LM Sphingosine kinase 1 in cancer. 2013 Adv. Cancer Res. pmid:23290781
Alshaker H et al. Therapeutic potential of targeting SK1 in human cancers. 2013 Adv. Cancer Res. pmid:23290780
Cuvillier O et al. Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. 2013 Adv. Cancer Res. pmid:23290779
Karapetyan AV et al. Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. 2013 Stem Cells Dev. pmid:23282236
Liang J et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. 2013 Cancer Cell pmid:23273921
Kleinjan A et al. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model. 2013 Allergy pmid:23253209
Billich A et al. Cellular assay for the characterization of sphingosine-1-phosphate lyase inhibitors. 2013 Anal. Biochem. pmid:23246729
Evindar G et al. Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1. 2013 Bioorg. Med. Chem. Lett. pmid:23245510
Xu Y et al. Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis. 2013 Am. J. Respir. Cell Mol. Biol. pmid:23239501
Park K et al. A novel role of a lipid species, sphingosine-1-phosphate, in epithelial innate immunity. 2013 Mol. Cell. Biol. pmid:23230267